Eaton Vance Management Seagen Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Seagen Inc. stock. As of the latest transaction made, Eaton Vance Management holds 51,299 shares of SGEN stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,299
Previous 50,491
1.6%
Holding current value
$0
Previous $8.93 Million
21.43%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding SGEN
# of Institutions
40Shares Held
1.26MCall Options Held
23KPut Options Held
55.2K-
Pictet Asset Management Sa Geneva 73, V8802KShares$00.19% of portfolio
-
Berry Street Capital Management LLP London, X0206KShares$012.86% of portfolio
-
Tekla Capital Management LLC112KShares$00.86% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC23KShares$02.7% of portfolio
-
Seeyond Paris, I014.3KShares$00.18% of portfolio
About Seagen Inc.
- Ticker SGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,664,992
- Description
- Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...